Explore the Global Aldosterone-Renin Screening Market — analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.

Future Market Insights

Aldosterone-Renin Screening Market

Key Insight

Aldosterone-renin screening sales will grow through 2036, led by immunoassay-based kits at 64% of the reagent kits segment in 2026. The market was valued at USD 574.80 million in 2025 and is expected to be worth USD 1185.22 million by 2036, creating an incremental opportunity of USD 571.33 million.

May 06, 2026

Anurag Sharma

250 Pages

Cite this Report

Aldosterone-Renin Screening Market

https://www.futuremarketinsights.com/reports/aldosterone-renin-screening-market

License

Buy Now

Summary ToC Infographics Companies

Key Players

ALPCO
Bio-Techne
EagleBio
Enzo Biochem Inc
Gold Standard Diagnostics
Immunodiagnostic Systems
Revvity
Thermo Fisher Scientific Inc.
Wuhan Fine Biotech Co. Ltd

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Aldosterone-Renin Screening Market

Key Players

Similar Industry Reports